Deutsch English Français

Contact

EP3821881

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP3821881

EP3821881 - DELAYED RELEASE COMPOSITIONS OF LINACLOTIDE [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 22.03.2024 Database last updated on 06.07.2024
Former	Request for examination was made Status updated on 25.02.2022
Former	The application has been published Status updated on 16.04.2021
Most recent event Tooltip	22.03.2024	New entry: Despatch of examination report + time limit
	22.03.2024	First examination report
Applicant(s)	For all designated states Ironwood Pharmaceuticals, Inc. 100 Summer Street, Suite 2300 Boston, MA 02110 / US
	For all designated states Forest Laboratories Holdings Limited Victoria Place, 5th Floor 31 Victoria Street Hamilton / BM
	[2021/20]
Inventor(s)	01 / FRETZEN, Angelika 7 Avon Street Somerville, MA Massachusetts 02143 / US
	02 / CURRIE, Mark G. 197 8th Street, PH21 Boston, MA Massachusetts 02129 / US
	03 / HASHASH, Ahmad 5 Oland Lane Southborough, MA Massachusetts 01772 / US
	04 / DEDHIYA, Mahendra 1 Lea Court Pomona, NY New York 10970 / US
	05 / MO, Yun 60 Fairfield Way Apt. 1 Commack, NY New York 11725 / US
	06 / CHHETTRY, Anil 11 Hickory Hill Drive Holtsville, NY New York 11742 / US
	07 / MILLER, Matthew 501 Harrison Street Apt. 416W Hoboken, NJ New Jersey 07030-6480 / US
	08 / SANGHVI, Ritesh 40 Fairfield Way Apt. 12 Commack, NY New York 11725 / US
	09 / BARI, Mohammad Mafruhul 14 Virginia Road Lake Grove, NY New York 11755 / US
	10 / GRILL, Andreas 5 June Street Hauppauge, NY New York 11788 / US
	[2021/20]
Representative(s)	Drywood, Rosalind Aerona, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
	[2021/20]
Application number, filing date	20198666.8	11.12.2014
	[2021/20]
Priority number, date	US201361914951P	11.12.2013 Original published format: US 201361914951 P
	US201361914952P	11.12.2013 Original published format: US 201361914952 P
	[2021/20]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP3821881
	Date:	19.05.2021
	Language:	EN
	[2021/20]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	30.03.2021
Classification	IPC:	A61K9/20, A61K9/28, A61K38/10, A61P1/00, A61P1/04, A61P1/10, A61P1/14, A61P35/00	[2021/20]
	CPC:	A61K38/10 (EP,IL,KR,US); A61K9/2846 (EP,IL,KR,US); A61K9/1611 (IL,US); A61K9/1617 (IL,US); A61K9/1635 (IL,US); A61K9/1652 (IL,US); (+) A61K9/1676 (IL,US); A61K9/2009 (EP,IL,KR,US); A61K9/2013 (EP,IL,KR,US); A61K9/2018 (EP,IL); A61K9/2027 (EP,IL,KR,US); A61K9/2054 (EP,IL); A61K9/284 (IL,US); A61K9/2886 (IL,KR,US); A61K9/4808 (IL,US); A61K9/4825 (IL,US); A61K9/485 (IL,US); A61K9/4858 (IL,US); A61K9/4866 (IL,US); A61K9/4891 (IL,KR,US); A61K9/5026 (IL,KR,US); A61K9/5042 (IL,KR,US); A61P1/00 (EP,IL); A61P1/04 (EP,IL); A61P1/10 (EP,IL); A61P1/14 (EP,IL); A61P35/00 (EP,IL); A61K2300/00 (IL,KR) (-)
	C-Set:	A61K38/10, A61K2300/00 (US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/13]
Former [2021/20]	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Extension states	BA	17.02.2022
	ME	17.02.2022
Title	German:	VERZÖGERT FREIGESETZTE ZUSAMMENSETZUNGEN AUS LINACLOTID	[2021/20]
	English:	DELAYED RELEASE COMPOSITIONS OF LINACLOTIDE	[2021/20]
	French:	COMPOSITIONS À LIBÉRATION RETARDÉE DE LINACLOTIDE	[2021/20]
Examination procedure	10.12.2021	Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time
	17.02.2022	Amendment by applicant (claims and/or description)
	17.02.2022	Examination requested [2022/13]
	17.02.2022	Date on which the examining division has become responsible
	21.03.2024	Despatch of a communication from the examining division (Time limit: M04)
Parent application(s) Tooltip	EP14824655.6 / EP3079669
Request for further processing for:	The application is deemed to be withdrawn due to non-payment of designation fees SK, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, TR, SM, SI, SE, RS, RO, PT, PL, NO, NL, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL
	17.02.2022	Request for further processing filed
	17.02.2022	Full payment received (date of receipt of payment) Request granted
	28.02.2022	Decision despatched
	The application is deemed to be withdrawn due to non-payment of the examination fee
	17.02.2022	Request for further processing filed
	17.02.2022	Full payment received (date of receipt of payment) Request granted
	28.02.2022	Decision despatched
	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	17.02.2022	Request for further processing filed
	17.02.2022	Full payment received (date of receipt of payment) Request granted
	28.02.2022	Decision despatched
Fees paid	Renewal fee
	12.01.2021	Renewal fee patent year 03
	12.01.2021	Renewal fee patent year 04
	12.01.2021	Renewal fee patent year 05
	12.01.2021	Renewal fee patent year 06
	12.01.2021	Renewal fee patent year 07
	30.11.2021	Renewal fee patent year 08
	13.10.2022	Renewal fee patent year 09
	15.11.2023	Renewal fee patent year 10
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[I]WO2010019266 (IRONWOOD PHARMACEUTICALS INC [US], et al) [I] 1-15,17-19 * page 8, lines 3-17 * * page 14, lines 1-25 * * page 19, lines 12-19 * * page 20, lines 22-29 * * page 31 - page 33; example 26 * * page 40 - page 41; example 56 *;
		[A]WO2011020054 (IRONWOOD PHARMACEUTICALS INC [US], et al) [A] 1-19 * page 2, paragraph l - page 3, paragraph l * * page 4, paragraph l * * page 7, paragraph 4 - page 9, paragraph 1 * * page 17, paragraph 8 - page 20, paragraph 1 * * claims 1-211 *;
		[A]US2011059903 (FRETZEN ANGELIKA [US], et al) [A] 1-19* the whole document *;
		[A]WO2012034068 (IRONWOOD PHARMACEUTICALS INC [US], et al) [A] 1-19 * the whole document *;
		[A]WO2013025969 (IRONWOOD PHARMACEUTICALS INC [US], et al) [A] 1-19 * page 2, paragraph 9 * * page 3, paragraph 12 * * page 12, paragraph 56 - page 25, paragraph 108 * * page 28, paragraph 131 * * page 29, paragraph 134 - page 30, paragraph 145 * * claims 1-81 *;
		[A]WO2013047795 (ASTELLAS PHARMA INC [JP]) [A] 1-19 * page 7, paragraph 14 - page 8, paragraph 14 * * page 25 - page 27; example 2 * * page 30 - page 34; examples 8,9 * * page 34 - page 35; comparative example 1 *;
		[I] - BLOMAIN ERIK S ET AL, "Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis", EXPERT REVIEW OF CLINICAL PHARMACOLOGY, (20130901), vol. 6, no. 5, ISSN 1751-2441, pages 557 - 564, XP008175159 [I] 16 * abstract * * page 561, column l, paragraph 2 - page 561, column r, paragraph 1 * DOI: http://dx.doi.org/10.1586/17512433.2013.827406
	by applicant	US7304036
		US7371727

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p